
    
      DRAGON III research, Neoadjuvant Chemotherapy (FLOT versus SOX) for Gastric Cancer, is an
      investigator initiated; phase II, open label, randomised controlled study. This study will be
      conducted and analyzed by the Gastrointestinal department（Unit III）of the Ruijin Hospital and
      the project is supported by the Institute of Digestive Surgery, Shanghai, which is a state
      key research center. This study will be monitored by the Clinical Research Center of the
      Ruijin hospital (Official body which is responsible to guide and monitor all types of
      research at Ruijin hospital). Primary endpoint and secondary endpoint is described above. The
      aim of this study to obtain preliminary result and further conduct a large scale multi-center
      randomised controlled trial(RCT) study.
    
  